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Gene expression microarrays provide a
snapshot of all the transcriptional activity
in a biological sample. Unlike most
traditional molecular biology tools, which
generally allow the study of a single gene
or a small set of genes, microarrays
facilitate the discovery of totally novel
and unexpected functional roles of genes.
The power of these tools has been applied
to a range of applications, including
discovering novel disease subtypes, devel-
oping new diagnostic tools, and identifying
underlying mechanisms of disease or drug
response. However, this technology neces-
sarily produces a large amount of data,
challenging us to interpret it by exploiting
modern computational and statistical
tools. In this brief review, we aim to
indicate the major issues involved in
microarray analysis and provide a useful
starting point for new microarray users.
Figure 1 outlines the steps in a typical
expression microarray experiment and
maps them to the different sections of this
review.
Experimental Design
Careful experimental design is crucial
for a successful microarray experiment
[1,2], yet this important step is often
shortchanged. Design issues depend in
part on the exact array technology used,
and indeed, choosing an array technology
is often the first design choice. The main
distinction is whether essentially full-length
transcripts are printed onto slides (cDNA
microarrays) or the desired—typically
shorter—oligonucleotides are synthesized
in situ (oligonucleotide arrays). While the
former may be less expensive because they
can be manufactured in the lab or at
institutional core facilities, the latter may
outperform the former in terms of number
of spots per array and the spots’ homoge-
neity [3,4].
Slightly different oligonucleotide array
platforms are manufactured by companies
such as Affymetrix, Agilent, and Nimble-
Gen (see Text S1 and Table S1 for further
discussion).
A major design question is whether to
measure the expression levels from each
sample on a different microarray (using
single-color, or single-channel, arrays), or
instead to compare relative expression
levels between a pair of samples on each
microarray (two-color or two-channel
arrays). There are tradeoffs between the
two approaches. Single-color arrays allow
for more flexibility in analysis, while two-
color arrays can control for some technical
issues by allowing a direct comparison in a
single hybridization [5]. A recent compar-
ison of single- and two-color methods on
the same platforms found good overall
agreement in the data produced by the
two methods [6]. cDNA arrays typically
involve two channels. Agilent and Nim-
bleGen arrays can be run using either one
or two channels. Affymetrix arrays are
inherently single-channel, though some
associated analysis tools facilitate pair-wise
comparisons.
Design issues for two-color arrays are
more complex [7]. Challenges include
ensuring that all samples can be compared
to the appropriate controls and avoiding
any biases introduced by the different
labeling. ‘‘Dye-swap’’ experiments, in
which the same pairs of samples are
compared twice with the labeling colors
swapped, can permit the computational
removal of such bias. Dye swapping
imposes additional costs in both the
number of arrays and the types of data
analyses possible. However, clever design
can somewhat reduce the required num-
ber of arrays [1].
As attractive as it might seem financially
to run just one microarray for each ‘‘class’’
of samples (of the same phenotype, time-
point, or tissue type) under consideration,
replicates are essential for providing
meaningful results [2]. Without replicates,
no statistical analysis of the significance
and reliability of the observed changes is
possible; the typical result is an increased
number of both false-positive and false-
negative errors in detecting differentially
expressed genes [8]. However, we distin-
guish between technological and biological
replicates. Technological replication—the
same biological material hybridized inde-
pendent times—is generally no longer
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Figure 1. Overview of steps in a typical
gene expression microarray experiment.
Topics in blue boxes with solid borders are
addressed in the Experimental Design section,
those in green boxes with dashed borders are
covered in the section on data preparation,
and those in purple boxes with dash-dotted
borders are discussed in the Data Analysis
section of this review.
doi:10.1371/journal.pcbi.1000543.g001
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the results will be relatively consistent
overall [4], although they may include
consistent sources of bias [2]. Instead,
different patients or animals from the same
class can serve as biological replicates. To
improve the ability to detect outliers and
their effects, we do not recommend
pooling samples unless necessary to obtain
sufficient amounts of material for hybrid-
ization, and even then, replicates measur-
ing different pools with the same pheno-
types must be performed [7].
During the experimental design stage, it
is important to identify all the variables to
be compared and to ensure that the
proposed design allows their measure-
ment. Be aware of other variables, such
as patient age or date of sample collection,
that might confound the distinction be-
tween the compared classes. One option is
to randomize confounding variables relat-
ed to experimental conditions under your
control.
Preparing Microarray Data for
Analysis
The task of analyzing microarray data is
often at least as much an art as a science,
and it typically consumes considerably
more time than the laboratory protocols
required to generate the data. Part of the
challenge is assessing the quality of the
data and ensuring that all samples are
comparable for further analysis.
Normalization of the raw data, which
controls for technical variation between
arrays within a study, is essential [7]. The
challenge of normalization is to remove as
much of the technical variation as possible
while leaving the biological variation
untouched. This is a big challenge, and
here we only touch upon the main issues.
First, visualization of the raw data is an
essential part of assessing data quality,
choosing a normalization method, and
estimating the effectiveness of the normal-
ization. Many methods for visualization,
quality assessment, and data normaliza-
tion have been developed (see [9] for a
review, Text S1, and Figure S1). Related
issues of background adjustment and data
‘‘summarization’’ (reducing multiple
probes representing a single transcript to
a single measurement of expression) for
Affymetrix arrays are well introduced in
chapter 2 of [10].
Clustering is a way of finding and
visualizing patterns in the data. Many
papers and indeed books have been
written on this topic (see e.g., [11–13]
and Text S1). Different methods highlight
different patterns, so trying more than one
method can be worthwhile. Note that
while clustering finds predominant pat-
terns in the data, those patterns may not
correspond to the phenotypic distinction
of interest in the experiment. To identify
gene expression patterns related to this
distinction, more directed methods are
appropriate.
Data Analysis
There are many commercial packages
for microarray analyses, and we have by
no means evaluated all of them. However,
commercial tools can be expensive, and
we find many that we have tried to have
limited flexibility. Fortunately, in the past
few years a number of Web-based tools
and open-source software packages for
microarray data analysis have become
available (see below and Text S1), and
we recommend taking advantage of them.
One common strategy is to create a
custom data analysis pipeline using statis-
tical analysis software packages such as
Matlab or R. Both allow great flexibility,
customized analysis, and access to many
specialized packages designed for analyz-
ing gene expression data. Not only is R
freely available, but it also allows the use of
BioConductor [14], a collection of R tools
including many powerful current gene
expression analysis methods written and
tested by experts from the growing micro-
array community.
The fundamental goal of most micro-
array experiments is to identify biological
processes or pathways that consistently
display differential expression between
groups of samples. While the exact
approach depends in part on the design
of the experiment, there are two broad
approaches to detecting differential ex-
pression. The first examines each gene or
transcript individually to find genes that,
by themselves, have statistically significant
differences in expression between samples
with different phenotypes or characteris-
tics. The set of genes thus identified is then
examined for over-representation of spe-
cific functions or pathways [15]. A pow-
erful alternative is to identify groups of
functionally related genes ahead of time
and to test whether these gene sets—as a
group—show differential expression
[16–18]. Both of these approaches can
be effective, and sometimes the combina-
tion of the two is stronger than either
alone [19].
One crucial issue for all microarray
analysis methods is adjusting for multiple
testing [20]. Each statistical test reports the
probability of seeing the observed test
score by chance under the null hypothesis
that there is no difference in expression
related to the phenotype being studied.
Even if this reported ‘‘p-value’’ is low, say
0.001, one might expect to see 20 of these
one-in-a-thousand events when perform-
ing 20,000 independent tests (a reasonable
number of genes on a microarray). A
range of methods to adjust for multiple
testing are available (see [21] for an
overview). The preferred approach for
microarray analysis is to control the
‘‘false-discovery rate’’ (FDR): the proba-
bility that any particular significant finding
is a false positive [22].
Once a list of differentially expressed
genes has been assembled, some functional
analysis is essential for interpreting the
results. There are many tools available to
identify pathways or biological functions
that are over-represented in a given gene
list. Again, adjustment for multiple testing
may be desirable, although complex
dependencies between pathways make
finding an appropriate adjustment method
controversial [23]. A good review of the
earlier tools that discusses many of the
statistical issues is [15].
An alternative to the individual-gene
analysis workflow is to consider entire gene
sets or pathways together when looking for
differential expression. There are many
approaches that do this (e.g., [16,24–26]),
but a fundamental and widely used version
is the Gene Set Enrichment Analysis
(GSEA) software from the Broad Institute
[17]. Gene set analysis can be advanta-
geous because it can detect subtle changes
in gene expression that individual gene
analyses can miss, and because it combines
identification of differential expression and
functional interpretation into a single step.
The disadvantage of this method is that
appropriate gene sets need to be known
ahead of time. When studying a biological
process that is still poorly understood, an
individual gene method may be more
appropriate, as it allows for the opportu-
nity of implicating hitherto unexpected
genes and gene sets. Given that gene set
analysis is more sensitive and therefore
potentially more powerful, a greater effort
in defining the pathways needed to
support this approach is warranted. To-
ward this end, GSEA’s gene set database
incorporates some computationally de-
rived gene sets, including expression
neighbors of known cancer genes [17]
and network modules mined from a large
collection of expression data [27]. Related
work has used conserved coexpression
[28] or differential coexpression [29] to
discover new functional modules.
Much has also been written about
sample classification using microarray data
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[30,31], microarrays themselves have not
been embraced as diagnostic tools. Rather,
they have been used to identify smaller sets
of predictive genes or pathways that
might, when assessed by other technolo-
gies, aid in diagnosis or stratification of
samples. A huge range of machine learn-
ing methods [11,12] can be applied to the
related classification problems. Most peo-
ple intent on doing this write their own
code (but see Text S1 for an alternative).
We note that simpler classification tools
often perform as well as, and generalize
better than, more complex ones [32].
Outlook
It has been our goal in this brief review
to demonstrate that it is currently feasible
for researchers with no previous experi-
ence to incorporate microarray analyses in
their studies. The field is now reasonably
mature, with available software and tools
to make data analysis manageable by
nonexperts. That said, newcomers to the
field should be aware that the data analysis
will require a dedicated commitment of
time and effort that generally substantially
exceeds that of data generation. We
strongly recommend that researchers do
the work to familiarize themselves with the
relevant analytical literature before begin-
ning, or even designing, the experiment.
It has been speculated that microarray
technology will soon be superseded by
next-generation sequencing, in which the
transcripts are directly sequenced by low-
cost, high-throughput sequencing technol-
ogies [33]. However, currently, next-
generation whole-transcriptome sequenc-
ing is still quite expensive and in its relative
infancy. Its cost scales proportionally with
its ability to assess low-abundance tran-
scripts, as sufficient depth of sequencing
must be performed. Further, analytic tools
specific to this data source have not yet
been developed for mass consumption.
Recent studies have shown that the two
transcriptomics technologies are expected
to give very similar results [34,35], al-
though for rare transcripts there is consid-
erably less correlation between the meth-
ods [35]. Thus, until sequencing-based
methods have become cost-effective and
easily used, microarrays will remain a
desirable alternative for many practition-
ers. We expect that, as RNA sequencing
methods mature, many microarray analy-
sis methods will come to be viewed as
general analysis tools that can be applied
or modified to fit any forthcoming tran-
scriptomics technologies [36].
Supporting Information
Figure S1 Three common normaliza-
tion methods. The left plots show pairs of
distributions of microarray intensities to be
normalized (right plots). A) If the distribu-
tions are of the same overall shape, they
can simply be scaled to the same mean. B)
Quantile normalization imposes the same
distribution on all samples. C) A known
quantity of RNA is spiked-in to each
sample (vertical line) and is then used as a
scaling factor.
Found at: doi:10.1371/journal.pcbi.
1000543.s001 (1.57 MB EPS)
Text S1 In this section we further discuss
some of the issues raised in the main text.
Found at: doi:10.1371/journal.pcbi.
1000543.s002 (0.23 MB RTF)
Table S1 Comparison of commercial
microarray manufacturers.
Found at: doi:10.1371/journal.pcbi.
1000543.s003 (0.05 MB RTF)
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